Investor Overview

Webcast ImageWebcast
Q4 2016 HTG Molecular Diagnostics Inc Earnings Conference Call (Replay)
03/23/17 at 5:00 p.m. ET
Q4 2016 HTG Molecular Diagnostics Inc Earnings Conference Call
Thursday, March 23, 2017 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

HTG Molecular Diagnostics, Inc's. (“HTG”) mission is to empower precision medicine at the local level. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of multiplexed profiling panels that leverage HTG’s proprietary target protection chemistry. In 2014, the company launched the HTG EdgeSeq system that combines the power of HTG Edge chemistry and automation with NGS technology. The HTG EdgeSeq system enables fast and easy use of NGS instruments for molecular profiling.

Stock Quote

HTGM (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.15 (1.55%)
Data as of 03/27/17 11:57 a.m. ET

Recent News

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results
HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN GeneReader NGS System
HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU
HTG Molecular Diagnostics to Hold 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 23, 2017
More News >>

Upcoming Events

There are currently no events scheduled.
More Events >>
Data provided by Nasdaq. Minimum 15 minutes delayed.

Shareholder Tools

Print Page Print Page   E-mail Page E-mail Page   RSS Feeds RSS Feeds   E-mail Alerts E-mail Alerts